Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
48 humanitarian NGOs adopt a joint statement
02/27/2015. Faced with growing threats to the safety of workers of humanitarian assistance, 48 NGOs reaffirm their commitment to humanitarian principles.
Peacekeepers Shouldn’t Always Be Peaceful
04/19/2018. The United Nations needs to accept that it’s possible to fight and broker peace agreements at the same time.
We CAN end hunger but only if we end conflict
November 2017. The vicious cycle of conflict and hunger must be broken if we are to achieve a world where everyone has enough to eat.
